TrialBMJ open2016

Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China.

Jing Jing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.